SecuAvail, Inc. AI Stock Analysis
Want to see JP:3042 full AI Analyst Report?
SecuAvail, Inc. (3042) AI Stock Analysis
SecuAvail, Inc.
(TSE/TYO:3042)
The company's score is primarily supported by its fortress-like balance sheet and a clear financial recovery, which provide a strong foundation. However, this is significantly offset by an extremely high valuation that leaves little room for error. Recent technical weakness, as shown by the oversold stochastic, adds a note of caution, resulting in a moderately positive overall score.
SecuAvail, Inc. (3042) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 5.66B
- Dividend Yield
- 0.66%
- Average Volume (3M)
- 2.76M
- Price to Earnings (P/E)
- 242.9
- Beta (1Y)
- 0.69
- Revenue Growth
- -0.89%
- EPS Growth
- -77.64%
- Country
- Japan
- Employees
- 116
- Sector
- Technology
- Sector Strength
- 61
- Industry
- Software - Infrastructure
SecuAvail, Inc. Business Overview & Revenue Model
Company Description
SecuAvail Inc., headquartered in Osaka, Japan, and founded in 2001, delivers extensive cybersecurity solutions across Japan. The company operates through two primary divisions: Information Security and Human Resource Services. Within its information...
SecuAvail, Inc. Financial Statement Overview
Summary
Financial performance is solid, driven by a strong balance sheet (Score 90) with virtually no debt. The income statement shows a clear recovery with expanding margins, though profitability is still maturing. Cash flow has turned positive but conversion remains moderate, tempering the overall financial picture.
Income Statement
75PositiveBalance Sheet
90Very PositiveCash Flow
65Positive| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.24B | 1.15B | 1.28B | 1.10B | 1.03B | 957.04M |
| Gross Profit | 531.12M | 450.75M | 580.47M | 443.09M | 412.58M | 371.57M |
| EBITDA | 114.49M | 36.05M | 116.99M | -18.29M | -19.43M | -72.83M |
| Net Income | 104.41M | 42.81M | 105.72M | 228.96M | -44.04M | -111.83M |
Balance Sheet | ||||||
| Total Assets | 1.51B | 1.55B | 1.58B | 1.48B | 1.33B | 1.36B |
| Cash, Cash Equivalents and Short-Term Investments | 1.14B | 1.11B | 1.13B | 1.20B | 769.49M | 811.06M |
| Total Debt | 1.75M | 2.27M | 7.79M | 4.32M | 6.29M | 0 |
| Total Liabilities | 309.74M | 367.68M | 297.42M | 337.30M | 265.33M | 253.35M |
| Stockholders Equity | 1.20B | 1.19B | 1.28B | 1.15B | 1.06B | 1.11B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -26.99M | 35.75M | -41.29M | -45.46M | -156.42M |
| Operating Cash Flow | 0 | -20.06M | 38.75M | -25.93M | -41.21M | -151.49M |
| Investing Cash Flow | 0 | -66.37M | -2.65M | 459.15M | 3.72M | 1.52M |
| Financing Cash Flow | 0 | -2.05M | -17.40M | -1.97M | -4.08M | -19.08M |
SecuAvail, Inc. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3042, the sentiment is Positive. The current price of 736.00 is below the 20-day moving average (MA) of 1028.85, above the 50-day MA of 636.00, and above the 200-day MA of 385.74, indicating a neutral trend. The MACD of 42.37 indicates Positive momentum. The RSI at 45.25 is Neutral, neither overbought nor oversold. The STOCH value of 12.11 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3042.
SecuAvail, Inc. Peers Comparison
Overall Rating
JP:447583Outperform
JP:304079Outperform
JP:369478Outperform
JP:441772Outperform
JP:449368Neutral
JP:304261Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 83Outperform | JPY 81.23B | 41.66 | ― | 0.46% | 17.01% | 34.74% | |
| 79Outperform | JPY 48.23B | 15.51 | 23.79% | 2.23% | 13.07% | 28.70% | |
| 78Outperform | JPY 24.15B | 20.41 | ― | ― | 21.05% | -2.47% | |
| 72Outperform | JPY 129.67B | 58.50 | ― | 0.51% | 25.18% | 85.59% | |
| 68Neutral | JPY 22.15B | 23.96 | ― | 0.22% | 22.65% | 74.18% | |
| Sector * | 61Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
| 61Neutral | JPY 5.80B | 242.90 | ― | 0.66% | -0.89% | -77.64% |
* Technology Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:3042 | SecuAvail, Inc. | 736.00 | 409.73 | 125.58% | |
| JP:3040 | Soliton Systems KK | 2600.00 | 845.09 | 48.16% | |
| JP:3694 | OPTiM Corp. | 431.00 | -127.00 | -22.76% | |
| JP:4417 | Global Security Experts Inc. | 8470.00 | 4928.52 | 139.17% | |
| JP:4475 | HENNGE K.K. | 2378.00 | 1039.55 | 77.67% | |
| JP:4493 | Cyber Security Cloud, Inc. | 2244.00 | 256.50 | 12.91% |
SecuAvail, Inc. Corporate Events
SecuAvail Reports Increased Cybersecurity Interest Since October
Since October 2026, SecuAvail has reported increased cybersecurity interest in Japan and overseas, with corporate and organizational inquiries trending upward. Awareness of cybersecurity needs has also risen among large enterprises and medium-sized a...
SecuAvail Reports Six-Month Sales Decline, Losses
SecuAvail Inc., listed on the Tokyo Stock Exchange and Sapporo Securities Exchange, reported consolidated results for the six months ended September 30, 2026. Sales fell 8.2% year on year to ¥584 million.The company recorded an operating loss of ¥23...
SecuAvail Nears Cap on Share Buyback, Signaling Focus on Shareholder Returns
SecuAvail Inc. has completed a share repurchase program authorized by its board in mid-August, buying back 196,000 common shares between October 1 and October 5 via market purchases on the Tokyo Stock Exchange. The latest tranche cost approximately ¥...
SecuAvail Advances Share Buyback Under ¥100 Million Repurchase Plan
SecuAvail Inc. has disclosed the progress of a share repurchase program authorized by its board on August 14, 2026, under provisions of the Companies Act and its Articles of Incorporation. Between September 1 and September 30, 2026, the company bough...
SecuAvail Starts Share Buyback Under ¥100 Million Repurchase Plan
SecuAvail Inc. has begun executing a previously approved share repurchase program, acquiring 53,100 shares of common stock on the Tokyo Stock Exchange between August 17 and August 31, 2026 for a total of ¥15,897,400. This initial tranche is part of a...
SecuAvail Swings to Q1 Loss as Large Software Deals Slow but Expects Year-End Rebound
SecuAvail reported first-quarter FY2027 consolidated net sales of ¥260.5 million, a 17.5% year-on-year decline, primarily because no large-scale software project was booked, although recurring stock-type service revenue held steady. The company poste...
SecuAvail Launches Share Buyback to Bolster Capital Efficiency
SecuAvail Inc. has approved a share buyback program, resolving to acquire up to 400,000 shares of its common stock, representing about 5.2 percent of its outstanding shares excluding treasury stock. The purchases, capped at 100 million yen, will be c...
SecuAvail Posts Quarterly Loss but Expects Full-Year Recovery
SecuAvail Inc. reported a weak start to its fiscal year ending March 31, 2027, posting a 17.5% year-on-year decline in net sales to ¥260 million for the three months ended June 30, 2026. The company swung to an operating loss of ¥52 million and a net...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 13, 2026
